Activation of AMP-activated protein kinase rapidly suppresses multiple pro-inflammatory pathways in adipocytes including IL-1 receptor-associated kinase-4 phosphorylation

Molecular and Cellular Endocrinology

Volumn 440, Issue , 2017, Pages 44-56

  Mancini, Sarah J ^a   White, Anna D ^a   Bijland, Silvia ^a   Rutherford, Claire ^a   Graham, Delyth ^a   Richter, Erik A ^b   Viollet, Benoit ^c,d,e   Touyz, Rhian M ^a   Palmer, Timothy M ^f   Salt, Ian P ^a  

^a UNIVERSITY OF GLASGOW   (United Kingdom)

^b UNIVERSITY OF COPENHAGEN   (Denmark)

^c INSTITUT COCHIN   (France)

^d CNRS   (France)

^e UNIVERSITÉ PARIS DESCARTES   (France)

^f UNIVERSITY OF BRADFORD   (United Kingdom)

Author keywords

Adipocyte; AMP activated protein kinase; Inflammation; Signalling

Indexed keywords

GAMMA INTERFERON INDUCIBLE PROTEIN 10; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE KINASE; I KAPPA B KINASE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 1 RECEPTOR ASSOCIATED KINASE 4; INTERLEUKIN 1BETA; INTERLEUKIN 6; JANUS KINASE; MITOGEN ACTIVATED PROTEIN KINASE KINASE 4; STAT3 PROTEIN; STRESS ACTIVATED PROTEIN KINASE; TUMOR NECROSIS FACTOR; 6,7 DIHYDRO 4 HYDROXY 3 (2' HYDROXY 1,1' BIPHENYL 4 YL) 6 OXOTHIENO[2,3 B]PYRIDINE 5 CARBONITRILE; CXCL10 PROTEIN, HUMAN; INTERLEUKIN 1 RECEPTOR ASSOCIATED KINASE; INTERLEUKIN 6 RECEPTOR; MESSENGER RNA; PYRONE DERIVATIVE; THIOPHENE DERIVATIVE;

ADIPOCYTE; ADIPOGENESIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DOWN REGULATION; ENZYME ACTIVATION; ENZYME PHOSPHORYLATION; FEMALE; IN VIVO STUDY; INFLAMMATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; 3T3-L1 CELL LINE; ANIMAL; DRUG EFFECTS; ENZYMOLOGY; GENETICS; HUMAN; METABOLISM; PATHOLOGY; PHOSPHORYLATION;

3T3-L1 CELLS; ADIPOCYTES; ADIPOGENESIS; AMP-ACTIVATED PROTEIN KINASES; ANIMALS; CHEMOKINE CXCL10; ENZYME ACTIVATION; FEMALE; HUMANS; INFLAMMATION; INTERLEUKIN-1 RECEPTOR-ASSOCIATED KINASES; INTERLEUKIN-1BETA; INTERLEUKIN-6; MICE; NF-KAPPA B; PHOSPHORYLATION; PYRONES; RECEPTORS, INTERLEUKIN-6; RNA, MESSENGER; STAT3 TRANSCRIPTION FACTOR; THIOPHENES;

EID: 84996807783     PISSN: 03037207     EISSN: 18728057     Source Type: Journal    
DOI: 10.1016/j.mce.2016.11.010     Document Type: Article

References (62)

1. Alomar, S.Y., Zaibi, M.S., Kępczyńska, M.A., Gentili, A., Alkhuriji, A., Mansour, L., Dar, J.A., Trayhurn, P., PCR array and protein array studies demonstrate that IL-1β (interleukin-1β) stimulates the expression and secretion of multiple cytokines and chemokines in human adipocytes. Arch. Physiol. Biochem. 121 (2015), 187–193.
2. Bain, J., Plater, L., Elliott, M., Shpiro, N., Hastie, C.J., McLauchlan, H., Klevernic, I., Arthur, J.S., Alessi, D.R., Cohen, P., The selectivity of protein kinase inhibitors: a further update. Biochem. J. 408 (2007), 297–315.
3. Benziane, B., Björnholm, M., Lantier, L., Viollet, B., Zierath, J.R., Chibalin, A.V., AMP-activated protein kinase activator A-769662 is an inhibitor of the Na(+)-K(+)-ATPase. Am. J. Physiol. Cell. Physiol. 297 (2009), C1554–C1566.
4. Bess, E., Fisslthaler, B., Frömel, T., Fleming, I., Nitric oxide-induced activation of the AMP-activated protein kinase α2 subunit attenuates IκB kinase activity and inflammatory responses in endothelial cells. PLoS One, 6, 2011, e20848.
5. Bijland, S., Mancini, S.J., Salt, I.P., Role of AMP-activated protein kinase in adipose tissue metabolism and inflammation. Clin. Sci. (Lond) 124 (2013), 491–507.
6. Boyle, J.G., Logan, P.J., Jones, G.C., Small, M., Sattar, N., Connell, J.M., Cleland, S.J., Salt, I.P., AMP-activated protein kinase is activated in adipose tissue of individuals with type 2 diabetes treated with metformin: a randomised glycaemia-controlled crossover study. Diabetologia 54 (2011), 1799–1809.
7. Brenner, D., Blaser, H., Mak, T.W., Regulation of tumour necrosis factor signalling: live or let die. Nat. Rev. Immunol. 15 (2015), 362–374.
8. Castanares-Zapatero, D., Bouleti, C., Sommereyns, C., Gerber, B., Lecut, C., Mathivet, T., Horckmans, M., Communi, D., Foretz, M., Vanoverschelde, J.L., Germain, S., Bertrand, L., Laterre, P.F., Oury, C., Viollet, B., Horman, S., Beauloye, C., Connection between cardiac vascular permeability, myocardial edema, and inflammation during sepsis: role of the α1AMP-activated protein kinase isoform. Crit. Care. Med. 41 (2013), e411–e422.
9. Chen, Y., Xu, X., Zhang, Y., Liu, K., Huang, F., Liu, B., Kou, J., Diosgenin regulates adipokine expression in perivascular adipose tissue and ameliorates endothelial dysfunction via regulation of AMPK. J. Steroid Biochem. Mol. Biol. 155 (2016), 155–165.
10. Cohen, P., The TLR and IL-1 signalling network at a glance. J. Cell. Sci. 127 (2014), 2383–2390.
11. Coughlan, K.A., Valentine, R.J., Ruderman, N.B., Saha, A.K., AMPK activation: a therapeutic target for type 2 diabetes?. Diabetes Metab. Syndr. Obes. 7 (2014), 241–253.
12. Dong, Y., Zhang, M., Liang, B., Xie, Z., Zhao, Z., Asfa, S., Choi, H.C., Zou, M.H., Reduction of AMP-activated protein kinase alpha2 increases endoplasmic reticulum stress and atherosclerosis in vivo. Circulation 121 (2010), 792–803.
13. Ewart, M.A., Kohlhaas, C.F., Salt, I.P., Inhibition of tumour necrosis factor-alpha-stimulated monocyte adhesion to human aortic endothelial cells by AMP-activated protein kinase. Arterioscler. Thromb. Vasc. Biol. 28 (2008), 2255–2257.
14. Flannery, S., Bowie, A.G., The interleukin-1 receptor-associated kinases: critical regulators of innate immune signalling. Biochem. Pharmacol. 80 (2010), 1981–1991.
15. Foretz, M., Hébrard, S., Leclerc, J., Zarrinpashneh, E., Soty, M., Mithieux, G., Sakamoto, K., Andreelli, F., Viollet, B., Metformin inhibits hepatic gluconeogenesis in mice independently of the LKB1/AMPK pathway via a decrease in hepatic energy state. J. Clin. Investig. 120 (2010), 2355–2369.
16. Fritzen, A.M., Lundsgaard, A.M., Jordy, A.B., Poulsen, S.K., Stender, S., Pilegaard, H., Astrup, A., Larsen, T.M., Wojtaszewski, J.F., Richter, E.A., Kiens, B., New nordic diet-induced weight loss is accompanied by changes in metabolism and AMPK signaling in adipose tissue. J. Clin. Endocrinol. Metab. 100 (2015), 3509–3519.
17. Galic, S., Fullerton, M.D., Schertzer, J.D., Sikkema, S., Marcinko, K., Walkley, C.R., Izon, D., Honeyman, J., Chen, Z.P., van Denderen, B.J., Kemp, B.E., Steinberg, G.R., Hematopoietic AMPK β1 reduces mouse adipose tissue macrophage inflammation and insulin resistance in obesity. J. Clin. Investig. 121 (2011), 4903–4915.
18. García-García, C., Fumarola, C., Navaratnam, N., Carling, D., López-Rivas, A., AMPK-independent down-regulation of cFLIP and sensitization to TRAIL-induced apoptosis by AMPK activators. Biochem. Pharmacol. 79 (2010), 853–863.
19. Gauthier, M.S., O'Brien, E.L., Bigornia, S., Mott, M., Cacicedo, J.M., Xu, X.J., Gokce, N., Apovian, C., Ruderman, N., Decreased AMP-activated protein kinase activity is associated with increased inflammation in visceral adipose tissue and with whole-body insulin resistance in morbidly obese humans. Biochem. Biophys. Res. Commun. 404 (2011), 382–387.
20. Göransson, O., McBride, A., Hawley, S.A., Ross, F.A., Shpiro, N., Foretz, M., Viollet, B., Hardie, D.G., Sakamoto, K., Mechanism of action of A-769662, a valuable tool for activation of AMP-activated protein kinase. J. Biol. Chem. 282 (2007), 32549–32560.
21. Green, C.J., Macrae, K., Fogarty, S., Hardie, D.G., Sakamoto, K., Hundal, H.S., Counter-modulation of fatty acid-induced pro-inflammatory nuclear factor κB signalling in rat skeletal muscle cells by AMP-activated protein kinase. Biochem. J. 435 (2011), 463–474.
22. Guigas, B., Bertrand, L., Taleux, N., Foretz, M., Wiernsperger, N., Vertommen, D., Andreelli, F., Viollet, B., Hue, L., 5-Aminoimidazole-4-carboxamide-1-beta-D-ribofuranoside and metformin inhibit hepatic glucose phosphorylation by an AMP-activated protein kinase-independent effect on glucokinase translocation. Diabetes 55 (2006), 865–874.
23. Habinowski, S.A., Witters, L.A., The effects of AICAR on adipocyte differentiation of 3T3-L1 cells. Biochem. Biophys. Res. Commun. 286 (2001), 1195–1207.
24. Hawley, S.A., Ross, F.A., Chevtzoff, C., Green, K.A., Evans, A., Fogarty, S., Towler, M.C., Brown, L.J., Ogunbayo, O.A., Evans, A.M., Hardie, D.G., Use of cells expressing gamma subunit variants to identify diverse mechanisms of AMPK activation. Cell Metab. 11 (2010), 554–565.
25. Jeong, H.W., Hsu, K.C., Lee, J.W., Ham, M., Huh, J.Y., Shin, H.J., Kim, W.S., Kim, J.B., Berberine suppresses proinflammatory responses through AMPK activation in macrophages. Am. J. Physiol. Endocrinol. Metab. 296 (2009), E955–E964.
26. Jørgensen, S.B., Viollet, B., Andreelli, F., Frøsig, C., Birk, J.B., Schjerling, P., Vaulont, S., Richter, E.A., Wojtaszewski, J.F., Knockout of the alpha2 but not alpha1 5'-AMP-activated protein kinase isoform abolishes 5-aminoimidazole-4-carboxamide-1-beta-4-ribofuranosidebut not contraction-induced glucose uptake in skeletal muscle. J. Biol. Chem. 279 (2004), 1070–1079.
27. Kim, Y.M., Kim, M.Y., Kim, H.J., Roh, G.S., Ko, G.H., Seo, H.G., Lee, J.H., Chang, K.C., Compound C independent of AMPK inhibits ICAM-1 and VCAM-1 expression in inflammatory stimulants-activated endothelial cells in vitro and in vivo. Atherosclerosis 219 (2011), 57–64.
28. Kim, Y.D., Kim, Y.H., Cho, Y.M., Kim, D.K., Ahn, S.W., Lee, J.M., Chanda, D., Shong, M., Lee, C.H., Choi, H.S., Metformin ameliorates IL-6-induced hepatic insulin resistance via induction of orphan nuclear receptor small heterodimer partner (SHP) in mouse models. Diabetologia 55 (2012), 1482–1494.
29. Kwon, H., Laurent, S., Tang, Y., Zong, H., Vemulapalli, P., Pessin, J.E., Adipocyte-specific IKKβ signaling suppresses adipose tissue inflammation through an IL-13-dependent paracrine feedback pathway. Cell Rep. 9 (2014), 1574–1583.
30. Laderoute, K.R., Amin, K., Calaoagan, J.M., Knapp, M., Le, T., Orduna, J., Foretz, M., Viollet, B., 5'-AMP-activated protein kinase (AMPK) is induced by low-oxygen and glucose deprivation conditions found in solid-tumor microenvironments. Mol. Cell. Biol. 26 (2006), 5336–5347.
31. Lee, J.M., Kim, S.R., Yoo, S.J., Hong, O.K., Son, H.S., Chang, S.A., The relationship between adipokines, metabolic parameters and insulin resistance in patients with metabolic syndrome and type 2 diabetes. J. Int. Med. Res. 37 (2009), 1803–1812.
32. Lihn, A.S., Jessen, N., Pedersen, S.B., Lund, S., Richelsen, B., AICAR stimulates adiponectin and inhibits cytokines in adipose tissue. Biochem. Biophys. Res. Commun. 316 (2004), 853–858.
33. Lihn, A.S., Pedersen, S.B., Lund, S., Richelsen, B., The anti-diabetic AMPK activator AICAR reduces IL-6 and IL-8 in human adipose tissue and skeletal muscle cells. Mol. Cell. Endocrinol. 292 (2008), 36–41.
34. Lumeng, C.N., Bodzin, J.L., Saltiel, A.R., Obesity induces a phenotypic switch in adipose tissue macrophage polarization. J. Clin. Investig. 117 (2007), 175–184.
35. Meares, G.P., Qin, H., Liu, Y., Holdbrooks, A.T., Benveniste, E.N., AMP-activated protein kinase restricts IFN-γ signaling. J. Immunol. 190 (2013), 372–380.
36. 120 but reduces MCP-1 release in mature 3T3-L1 adipocytes: possible regulatory mechanism through endogenous ER stress and AMPK-related pathways. Biochem. Biophys. Res. Commun. 419 (2012), 200–205.
37. Moreno, D., Knecht, E., Viollet, B., Sanz, P., A769662, a novel activator of AMP-activated protein kinase, inhibits non-proteolytic components of the 26S proteasome by an AMPK-independent mechanism. FEBS Lett. 582 (2008), 2650–2654.
38. Mottillo, E.P., Desjardins, E.M., Crane, J.D., Smith, B.K., Green, A.E., Ducommun, S., Henriksen, T.I., Rebalka, I.A., Razi, A., Sakamoto, K., Scheele, C., Kemp, B.E., Hawke, T.J., Ortega, J., Granneman, J.G., Steinberg, G.R., Lack of adipocyte AMPK exacerbates insulin resistance and hepatic steatosis through brown and beige adipose tissue function. Cell Metab. 24 (2016), 118–129.
39. Nerstedt, A., Cansby, E., Amrutkar, M., Smith, U., Mahlapuu, M., Pharmacological activation of AMPK suppresses inflammatory response evoked by IL-6 signalling in mouse liver and in human hepatocytes. Mol. Cell. Endocrinol. 375 (2013), 68–78.
40. Qu, D., Liu, J., Lau, C.W., Huang, Y., IL-6 in diabetes and cardiovascular complications. Br. J. Pharmacol. 171 (2014), 3595–3603.
41. Rios, F.J., Neves, K.B., Nguyen Dinh Cat, A., Even, S., Palacios, R., Montezano, A.C., Touyz, R.M., Cholesteryl ester-transfer protein inhibitors stimulate aldosterone biosynthesis in adipocytes through nox-dependent processes. J. Pharmacol. Exp. Ther. 353 (2015), 27–34.
42. Ross, S.A., Song, X., Burney, M.W., Kasai, Y., Orlicky, D.J., Efficient adenovirus transduction of 3T3-L1 adipocytes stably expressing coxsackie-adenovirus receptor. Biochem. Biophys. Res. Commun. 302 (2003), 354–358.
43. Rotter, V., Nagaev, I., Smith, U., Interleukin-6 (IL-6) induces insulin resistance in 3T3-L1 adipocytes and is, like IL-8 and tumor necrosis factor-alpha, overexpressed in human fat cells from insulin-resistant subjects. J. Biol. Chem. 278 (2003), 45777–45784.
44. Rutherford, C., Speirs, C., Williams, J.J., Ewart, M.-A., Mancini, S.J., Hawley, S.A., Delles, C., Viollet, B., Costa-Pereira, A.P., Baillie, G.S., Salt, I.P., Palmer, T.M., Rapid AMP-activated protein kinase (AMPK) phosphorylation of Janus kinase 1 (JAK1) links energy sensing to anti-inflammatory signalling. Sci. Signal., 9, 2016, ra109.
45. Sag, D., Carling, D., Stout, R.D., Suttles, J., Adenosine 5’-monophosphate-activated protein kinase promotes macrophage polarisation to an anti-inflammatory functional phenotype. J. Immunol. 181 (2008), 8633–8641.
46. Salt, I.P., Palmer, T.M., Exploiting the anti-inflammatory effects of AMP-activated protein kinase activation. Expert Opin. Investig. Drugs 21 (2012), 1155–1167.
47. Scott, J.W., van Denderen, B.J., Jorgensen, S.B., Honeyman, J.E., Steinberg, G.R., Oakhill, J.S., Iseli, T.J., Koay, A., Gooley, P.R., Stapleton, D., Kemp, B.E., Thienopyridone drugs are selective activators of AMP-activated protein kinase beta1-containing complexes. Chem. Biol. 15 (2008), 1220–1230.
48. Shibata, T., Takaguri, A., Ichihara, K., Satoh, K., Inhibition of the TNF-α-induced serine phosphorylation of IRS-1 at 636/639 by AICAR. J. Pharmacol. Sci. 122 (2013), 93–102.
49. Sun, Y., Li, J., Xiao, N., Wang, M., Kou, J., Qi, L., Huang, F., Liu, B., Liu, K., Pharmacological activation of AMPK ameliorates perivascular adipose/endothelial dysfunction in a manner interdependent on AMPK and SIRT1. Pharmacol. Res. 89 (2014), 19–28.
50. Takahashi, K., Yamaguchi, S., Shimoyama, T., Seki, H., Miyokawa, K., Katsuta, H., Tanaka, T., Yoshimoto, K., Ohno, H., Nagamatsu, S., Ishida, H., JNK- and IkappaB-dependent pathways regulate MCP-1 but not adiponectin release from artificially hypertrophied 3T3-L1 adipocytes preloaded with palmitate in vitro. Am. J. Physiol. Endocrinol. Metab. 294 (2008), E898–E909.
51. Thiefes, A., Wolter, S., Mushinski, J.F., Hoffmann, E., Dittrich-Breiholz, O., Graue, N., Dörrie, A., Schneider, H., Wirth, D., Luckow, B., Resch, K., Kracht, M., Simultaneous blockade of NFkappaB, JNK, and p38 MAPK by a kinase-inactive mutant of the protein kinase TAK1 sensitizes cells to apoptosis and affects a distinct spectrum of tumor necrosis factor target genes. J. Biol. Chem. 280 (2005), 27728–27741.
52. Viollet, B., Horman, S., Leclerc, J., Lantier, L., Foretz, M., Billaud, M., Giri, S., Andreelli, F., AMPK inhibition in health and disease. Crit. Rev. Biochem. Mol. Biol. 45 (2010), 276–295.
53. Wang, D., Zhou, Y., Lei, W., Zhang, K., Shi, J., Hu, Y., Shu, G., Song, J., Signal transducer and activator of transcription 3 (STAT3) regulates adipocyte differentiation via peroxisome-proliferator-activated receptor gamma (PPARgamma). Biol. Cell. 102 (2009), 1–12.
54. Wang, S., Zhang, M., Liang, B., Xu, J., Xie, Z., Liu, C., Viollet, B., Yan, D., Zou, M.H., AMPKalpha2 deletion causes aberrant expression and activation of NAD(P)H oxidase and consequent endothelial dysfunction in vivo: role of 26S proteasomes. Circ. Res. 106 (2010), 1117–1128.
55. Wang, M., Gao, X.J., Zhao, W.W., Zhao, W.J., Jiang, C.H., Huang, F., Kou, J.P., Liu, B.L., Liu, K., Opposite effects of genistein on the regulation of insulin-mediated glucose homeostasis in adipose tissue. Br. J. Pharmacol. 170 (2013), 328–340.
56. Woods, A., Azzout-Marniche, D., Foretz, M., Stein, S.C., Lemarchand, P., Ferré, P., Foufelle, F., Carling, D., Characterization of the role of AMP-activated protein kinase in the regulation of glucose-activated gene expression using constitutively active and dominant negative forms of the kinase. Mol. Cell. Biol. 20 (2000), 6704–6711.
57. Wu, Y., Song, P., Zhang, W., Liu, J., Dai, X., Liu, Z., Lu, Q., Ouyang, C., Xie, Z., Zhao, Z., Zhuo, X., Viollet, B., Foretz, M., Wu, J., Yuan, Z., Zou, M.H., Activation of AMPKα2 in adipocytes is essential for nicotine-induced insulin resistance in vivo. Nat. Med. 21 (2015), 373–382.
58. Xu, X.J., Apovian, C., Hess, D., Carmine, B., Saha, A., Ruderman, N., Improved insulin sensitivity 3 Months after RYGB surgery is associated with increased subcutaneous adipose tissue AMPK activity and decreased oxidative stress. Diabetes 64 (2015), 3155–3159.
59. Yang, Z., Kahn, B.B., Shi, H., Xue, B.Z., Macrophage alpha1 AMP-activated protein kinase (alpha1AMPK) antagonises fatty acid-induced inflammation through SIRT1. J. Biol. Chem. 285 (2010), 19051–19059.
60. Zaha, V.G., Qi, D., Su, K.N., Palmeri, M., Lee, H.Y., Hu, X., Wu, X., Shulman, G.I., Rabinovitch, P.S., Russell, R.R., Young, L.H., AMPK is critical for mitochondrial function during reperfusion after myocardial ischemia. J. Mol. Cell. Cardiol. 91 (2016), 104–113.
61. Zhang, Y., Qiu, J., Wang, X., Xia, M., AMP-activated protein kinase suppresses endothelial cell inflammation through phosphorylation of transcriptional coactivator p300. Arterioscler. Thromb. Vasc. Biol. 31 (2011), 2897–2908.
62. Zhao, W., Wang, M., Shao, L., Liao, M., Liu, K., Huang, F., Liu, B., The total phenolic fraction of Anemarrhena asphodeloides inhibits inflammation and reduces insulin resistance in adipocytes via regulation of AMP-kinase activity. Planta. Med. 80 (2014), 146–152.